nach oben

Inflammopharmacology

Erschienen in:

05.03.2020 | Original Article

Apixaban exhibits anti-arthritic effects by inhibiting activated factor X-mediated JAK2/STAT3 and MAPK phosphorylation pathways

verfasst von: Omnia Ahmed Mohamed Abd El-Ghafar, Gouda Kamel Helal, Amira M. Abo-Youssef

Erschienen in: Inflammopharmacology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Activated factor X (FXa) is strongly linked to various inflammatory events. This study aimed to investigate the effect of FXa on janus kinase2/signal transducers and activators of transcription3 (JAK2/STAT3) and mitogen-activated protein kinase (MAPK) phosphorylation in relation to rheumatoid arthritis (RA). It also extends its scope to explore the possible anti-arthritic effects of apixaban, a selective FXa inhibitor. Rats were allocated into normal control; complete Freund's adjuvant (CFA, 0.4 ml/4 days/12 days); FXa (120 µg/kg/day/3 days) and CFA + FXa groups as well as three treated groups including CFA + apixaban; FXa + apixaban and CFA + FXa + apixaban. Apixaban was administered at a dose of 10 mg/kg/12 h for15 days. By the end of the experimental period, tissue samples were collected for the assessment of phosphorylated (p)-JAK2, STAT3, MAPK, matrixmetalloprotein-1 (MMP-1) and protease-activated receptor 2. Furthermore, Serum interleukin-6 (IL-6), platelet-derived growth factor (PDGF), anti-citrullinated protein antibody (ACPA), 8-hydroxy-2′-deoxyguanosine (8-OHdG), plasma level of FXa and prothrombin time were evaluated. In support, histopathological and macroscopical examinations were performed. FXa activated JAK2, STAT3 and MAPK phosphorylation through activation of PAR 2, PDGF and IL-6 and concomitantly led to a significant elevation in ACPA, MMP-1 and 8-OHdG. Apixaban markedly amended FXa-induced changes. Conclusively, the current study revealed that FXa may have a drastic role in RA progression and pathogenesis at least through stimulation of JAK2/STAT3 and MAPK phosphorylation. Furthermore, apixaban exerted robust arthro-protective effects. These beneficial outcomes could be attributed to its ability to impede JAK2/STAT3 and MAPK activation, as well as to its antioxidant property.

Ahmad SF, Ansari MA, Zoheir KM, Bakheet SA, Korashy HM, Nadeem A, Ashour AE, Attia SM (2015) Regulation of TNF-α and NF-κB activation through the JAK/STAT signaling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation. Immunobiology 220:889–898. https://doi.org/10.1016/j.imbio-2015-01-008CrossRefPubMed

Andziak B, O'Connor TP, Qi W, DeWaal EM, Pierce A, Chaudhuri AR, Van Remmen H, Buffenstein R (2006) High oxidative damage levels in the longest-living rodent, the naked mole-rat. Aging Cell 5:463–471. https://doi.org/10.1111/j.1474-9726-2006-00237CrossRefPubMed

Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, Kaneko K, Kobayashi M, Iwane A, Sasako T, Okazaki Y, Ohsugi M, Takamoto I, Yamashita S, Asahara H, Akira S, Kasuga M, Kadowaki T (2011) Article adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13:401–412. https://doi.org/10.1016/j.cmet.2011.02.010CrossRefPubMed

Bae J, Yang L, Rezaie AR (2010) Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment. J Biol Chem 285:34803–34812. https://doi.org/10.1074/jbc.M110.163642CrossRefPubMedPubMedCentral

Barakat A, Szick-miranda K, Chang I, Guyot R, Blanc G, Cooke R, Delseny M, Bailey-serres J (2001) The organization of cytoplasmic ribosomal protein genes in the arabidopsis genome 1. Plant Physiol 127:398–415. https://doi.org/10.1104/pp.010265.398CrossRefPubMedPubMedCentral

Barrett YC, Wang J, Knabb R, Mohan P (2011) Apixaban decreases coagulation activity in patients with acute deep-vein thrombosis. Thromb Haemost 105:181–189. https://doi.org/10.1160/TH10-06-0393CrossRefPubMed

Borensztajn K, Stiekema J, Nijmeijer S, Reitsma PH, Peppelenbosch MP, Spek CA (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 172:309–320. https://doi.org/10.2353/ajpath.2008.070347CrossRefPubMedPubMedCentral

Cirino G, Cicala C, Bucci M, Sorrentino L, Ambrosini G, DeDominicis G, Altieri DC (1997) Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest 99:2446–2451CrossRef

Coenen D, Verschueren P, Bossuyt X, Euroimmun AI, Ccp E, Lite Q, Igg CP, Inova E (2007) Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 504:498–504. https://doi.org/10.1373/clinchem.2006.078063CrossRef

Daha NA, Toes RE (2011) Rheumatoid arthritis: are ACPA-positive and ACPA-negative RA the same disease? Nat Publ Gr 7:202–203. https://doi.org/10.1038/nrrheum.2011.28CrossRef

D'Angelo A, Seveso MP, D'Angelo SV, Gilardoni F, Macagni A, Manotti C, Bonini P (1989) Comparison of two automated coagulometers and the manual tilt-tube method for the determination of prothrombin time. Am J Clin Pathol 92:321–328CrossRef

Doronin K, Flatt JW, Paolo NC, Khare R, Bammler TK, Beyer RP, Farin FM (2012) Coagulation factor X activates innate immunity to human species C adenovirus. Sciencexpress. https://doi.org/10.1038/nature03712CrossRef

El-Gaphar OA, Abo-Youssef AM, Helal GK (2017) Bacterial lipopolysaccharide vigorously activate JAK2/STAT3 induced rheumatoid arthritis collate with complete freund’s adjuvant in experimental rats. Biomed Pharmacol J 10:2071–2076. https://doi.org/10.13005/bpj-1329CrossRef

El-Gaphar OA, Abo-Youssef AM, Halal GK (2018) Levetiracetam mitigates lipopolysaccharide-induced JAK2/STAT3 and TLR4/MAPK signaling pathways activation in a rat model of adjuvant-induced arthritis. Eur J Pharmacol 826:85–95. https://doi.org/10.1016/j.ejphar-2018-02-041CrossRef

Gonca E (2015) Comparison of thiopental and ketamine + xylazine anesthesia in ischemia/reperfusion-induced arrhythmias in rats. Turk J Med Sci 1420:1413–1420. https://doi.org/10.3906/sag-1403-25CrossRef

Hollborn M, Kohen L, Werschnik C, Tietz L, Wiedemann P, Bringmann A (2012) Activated blood coagulation factor X (FXa) induces angiogenic growth factor expression in human retinal pigment epithelial cells. Res Vis Ophthalmol 49:1–25

Ivashkiv LB, Hu X (2003) The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective ? Arthritis Rheum 48:2092–2096. https://doi.org/10.1002/art.11095CrossRefPubMed

Kawai N, Nakamura T, Nagao S (2006) Early hemostatic therapy using recombinant factor VIIa in a collagenase-induced intracerebral hemorrhage model in rats. Brain Edema 20:212–217CrossRef

Kelso EB, Ferrell WR, Lockhart JC, Elias-jones I, Hembrough T, Dunning L, Gracie JA, Mcinnes IB (2007) Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium ex vivo studies using a novel proteinase-activated receptor 2 antagonist. Arthritis Rheum 56:765–771. https://doi.org/10.1002/art.22423CrossRefPubMed

Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K (2014) Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat. Stroke 45:2404–2410. https://doi.org/10.1161/STROKEAHA.114.005316CrossRefPubMed

Krishnamurthy A, Joshua V, Hensvold AH, Jin T, Sun M, Vivar N, Ytterberg AJ, Engström M, Fernandes-cerqueira C, Amara K, Magnusson M, Wigerblad G, Kato J, Jiménez-andrade JM, Tyson K, Rapecki S, Lundberg K, Catrina S, Jakobsson P, Svensson C, Malmström V, Klareskog L, Wähämaa H, Catrina AI (2016) Identi fi cation of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis 75:721–729. https://doi.org/10.1136/annrheumdis-2015-208093CrossRefPubMed

Li R, Cai L, Ren D, Xie X, Hu C, Li J (2012) International immunopharmacology therapeutic effect of 7,3′-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway. Int Immunopharmacol 14:157–163. https://doi.org/10.1016/j.intimp.2012.07.001CrossRefPubMed

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262CrossRef

Massberg S, Grahl L, Bruehl M, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I, Kennerknecht E, Reges K, Holdenrieder S, Braun S, Reinhardt C, Spannagl M, Preissner KT, Engelmann B (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887–896. https://doi.org/10.1038/nm.2184CrossRefPubMed

Mcinnes IB, Schett G (2012) The Pathogenesis of rheumatoid arthritis. N Engl J Med Rev 23:2205–2219

Morser J (2012) Thrombomodulin links coagulation to inflammation and immunity. Curr Drug Targets 13:421–431. https://doi.org/10.2174/138945012799424606CrossRefPubMed

Muhlestein JB (2010) Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost 103:71–82. https://doi.org/10.1160/TH09-03-0177CrossRefPubMed

Murray PJ, Murray PJ (2017) The JAK-STAT signaling pathway: input and output integration. J Immunol 178:2623–2629. https://doi.org/10.4049/jimmunol.178.5.2623CrossRef

Nakase T, Moroi J, Ishikawa T (2018) Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients. Clin Transl Med 7:1–7. https://doi.org/10.1186/s40169-017-0179-9CrossRef

Neurath MF, Finotto S (2011) Cytokine and growth factor reviews IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22:83–89. https://doi.org/10.1016/j.cytogfr.2011.02.003CrossRefPubMed

Novotny F, Miletich P (1988) The Lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa. Blood 71:335–343CrossRef

Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD (2012) Interactions between coagulation and complement—their role in inflammation. Semin Immunopathol 34:151–165. https://doi.org/10.1007/s00281-011-0280-xCrossRefPubMed

Pawlak K, Borawski J, Naumnik B, Mysliwiec M (2003) Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients. Thromb Res 109:247–251. https://doi.org/10.1016/S0049-3848(03)00241-XCrossRefPubMed

Poll T, Daan J, Boer D, Levi M (2011) The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis 24:273–278. https://doi.org/10.1097/QCO.0b013e328344c078CrossRefPubMed

Review I (2011) Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation. J Thromb Haemost 9:168–173. https://doi.org/10.1111/j.1538-7836.2011.04319.xCrossRef

Sansone P, Bromberg J (2017) Targeting the interleukin-6/Jak/Stat pathway in human malignancies. J Clin Oncol 30:1005–1014. https://doi.org/10.1200/JCO.2010.31.8907CrossRef

Schett G, Zwerina J, Firestein G (2008) The p38 mitogen-activated protein kinase ( MAPK ) pathway in rheumatoid arthritis. Ann Rheum Dis 67:909–916. https://doi.org/10.1136/ard.2007.074278CrossRefPubMed

Schuliga M (2015) The inflammatory actions of coagulant and fibrinolytic proteases in disease. Mediat Inflammatio 2015:1–9CrossRef

Seevaratnam R, Patel BP, Hamadeh MJ (2009) Comparison of total protein concentration in skeletal muscle as measured by the bradford and lowry assays. J Biochem 145:791–797. https://doi.org/10.1093/jb/mvp037CrossRefPubMed

Senden NH, Jeunhomme TM, Johan W, Heemskerk M, Wagenvoord R, Van VC, Hemker C, Buurman WA (2016) Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 161:4318–4324

Soo K, Hyun K, Choi M (2011) Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int 31:543–547. https://doi.org/10.1007/s00296-010-1592-1CrossRef

Takeda M, Ito W, Tanabe M, Ueki S, Kato H, Kihara J, Tanigai T, Chiba T, Yamaguchi K, Kayaba H, Imai Y, Okuyama K, Ohno I, Sasaki T, Chihara J (2009) Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase γ–deficient mice. J Allergy Clin Immunol 123(4):805–812CrossRef

Vainchenker W, Constantinescu SN (2013) JAK/STAT signaling in hematological malignancies. Oncogene 12:2601–2613. https://doi.org/10.1038/onc.2012.347CrossRef

Vignais M, Sadowski HB, Watling D, Rogers NC, Gilman M (1996) Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 16:1759–1769CrossRef

Wang H, Fang Y, Wang Y, Wang Z, Zou Q, Shi Y, Chen J, Peng D (2012) Inhibitory effect of curcumol on Jak2-STAT signal pathway molecules of fibroblast-like synoviocytes in patients with rheumatoid arthritis. Evid Based Complement Altern 2012:1–8. https://doi.org/10.1155/2012/746426CrossRef

Zhou Q, Bea F, Preusch M, Wang H, Isermann B, Shahzad K, Katus HA, Blessing E (2011) Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban. Mediators Inflamm 2011:1–9. https://doi.org/10.1155/2011/432080CrossRef

Zimmermann B, Neumann E, Lefe S, Gay S, Mu U (2010) Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 16:458–468. https://doi.org/10.1016/j.molmed.2010.07.004CrossRefPubMed

Titel: Apixaban exhibits anti-arthritic effects by inhibiting activated factor X-mediated JAK2/STAT3 and MAPK phosphorylation pathways
verfasst von: Omnia Ahmed Mohamed Abd El-Ghafar
Gouda Kamel Helal
Amira M. Abo-Youssef
Publikationsdatum: 05.03.2020
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 5/2020
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-020-00693-8

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Metformin ameliorates animal models of dermatitis

Modulation of inflammatory pathways, medicinal uses and toxicities of Uvaria species: potential role in the prevention and treatment of inflammation

A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms

Conditional nutrition (I): concerning zinc as a beneficial but variable regulator of inflammation and experimental arthritis

The advances of methotrexate resistance in rheumatoid arthritis

Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways